Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Abstract: “Input uncertainty” refers to the (often unmeasured) effect of not knowing the true, correct distributions of the basic stochastic processes that drive the simulation. These include, for ...

This example illustrates how to implement cascading combo boxes scenario within the MVC ComboBox Extension. It is an illustration of the KA18675: MVC ComboBox Extension - How to implement cascaded ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...

Cadonilimab combined with chemotherapy achieved an 81.4% objective response rate and 97.7% disease control rate in advanced ESCC patients. The treatment demonstrated efficacy across all patient ...

Merck (NYSE:MRK) and Eisai (OTCPK:ESALF) Tuesday said that their Phase 3 LITESPARK-011 trial met a key goal, showing improved progression-free survival for patients with advanced kidney cancer treated ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

"Achieving breakthrough results in production at high volume is a significant milestone for Silicon Box, as well as for transitioning the industry towards more scalable and low-cost design and ...

Breakthrough yield and device performance at high volume show team can scale company's large-format advanced packaging for customers' cutting-edge applications SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- ...

A new drug combo is more effective in treating advanced prostate cancer The targeted drug niraparib added to hormone therapy slowed cancer growth and symptom progression Signs show the combo might ...